Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) — Cash Flow Quality Index
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) has a Cash Flow Quality Index of 4.38x as of December 2025. Operating cash flow of CN¥837.18 Million exceeds net income of CN¥191.35 Million, indicating high earnings quality where cash backs reported profits. Explore 301408 operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 301408 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (2021–2025)
Year-by-year earnings quality comparison for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A. For live market cap and the full company financial profile, see Anhui Huaren Health Pharmaceutical Co. L market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.38x | CN¥837.18 Million | CN¥191.35 Million | ▲ +5.4% |
| 2024 | 4.15x | CN¥571.76 Million | CN¥137.70 Million | ▲ +262.4% |
| 2023 | 1.15x | CN¥131.37 Million | CN¥114.67 Million | ▲ +6.0% |
| 2022 | 1.08x | CN¥173.84 Million | CN¥160.78 Million | ▼ -46.5% |
| 2021 | 2.02x | CN¥140.82 Million | CN¥69.73 Million | — |